ADIAL PHARMACEUTICALS, INC.·4

May 25, 4:50 PM ET

Truluck Joseph 4

4 · ADIAL PHARMACEUTICALS, INC. · Filed May 25, 2023

Insider Transaction Report

Form 4
Period: 2023-05-23
Truluck Joseph
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-05-23+157,500265,139 total
  • Award

    Stock Option (Right to Buy)

    2023-05-23+125,000125,000 total
    Exercise: $0.30From: 2023-05-23Exp: 2033-05-23Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary